Biotechnology Assets S.A. Capital Reinvestment Ratio
Biotechnology Assets S.A. capital reinvestment ratio. Biotechnology Assets S.A. (BST) has a Capital Reinvestment Ratio of 0.00x as of June 2025, meaning it reinvests 0% of its operating cash flow (€658.13K) in capital expenditures (€1.99K). Check BST cash flow reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Capital Reinvestment Ratio of Biotechnology Assets S.A. (2015–2023)
Capital reinvestment ratio of Biotechnology Assets S.A. from 2015 to 2023. This chart tracks Biotechnology Assets S.A.'s Capital Reinvestment Ratio across 5 annual periods. Also explore how fast is Biotechnology Assets S.A. growing its equity to track the company's year-over-year net asset growth rate.
Biotechnology Assets S.A. Capital Reinvestment Ratio by Year (2015–2023)
Biotechnology Assets S.A. capital reinvestment ratio by year from 2015 to 2023. For the full cash flow conversion analysis, see BST cash generation efficiency.
| Year | Reinvestment Ratio | Operating CF (EUR) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2023 | 6.83x | €47.74K | €325.97K | ▲ +15235.3% |
| 2020 | 0.04x | €8.79 Million | €391.53K | ▼ -99.4% |
| 2017 | 7.33x | €213.49K | €1.56 Million | ▲ +508.5% |
| 2016 | 1.20x | €2.71 Million | €3.27 Million | ▼ -82.2% |
| 2015 | 6.75x | €158.16K | €1.07 Million | — |